We are live on ! Find out more
CRBP icon

Corbus Pharmaceuticals
CRBP

80 hedge funds and large institutions have $62.5M invested in Corbus Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 29 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $55.4M → $62.5M (+$7.13M)

7% less funds holding

Funds holding: 86 → 80 (-6)

11.23% less ownership

Funds ownership: 85.29% → 74.06% (-11%)

14% less call options, than puts

Call options by funds: $138K | Put options by funds: $161K

29% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 21

41% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 29

Holders
80
Holders Change
-6
Holders Change %
-6.98%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
17
Reduced
29
Closed
21
Calls
$138K
Puts
$161K
Net Calls
-$23K
Net Calls Change
+$51K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$598K
2
HP
HealthInvest Partners
Sweden
+$561K
3
Millennium Management
Millennium Management
New York
+$418K
4
Bank of America
Bank of America
North Carolina
+$402K
5
Aberdeen Group
Aberdeen Group
United Kingdom
+$329K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$3.59M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.39M
3
State Street
State Street
Massachusetts
-$1.22M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$998K
5
Citadel Advisors
Citadel Advisors
Florida
-$676K
Name Holding Trade Value Shares
Change 		Change in
Stake
NA
76
NewEdge Advisors
Louisiana
$55 -$7 -1 -11%
EB
77
Eastern Bank
Massachusetts
$41 – – –
SA
78
Scarborough Advisors
Maryland
$41 +$44 +6 New
BL
79
BFSG LLC
California
$7 – – –
CIBC Private Wealth Group
80
CIBC Private Wealth Group
Georgia
$7 – – –
Citadel Advisors
81
Citadel Advisors
Florida
– -$676K -92,991 Closed
N
82
Nuveen
North Carolina
– -$243K -45,689 Closed
SCM
83
Stonepine Capital Management
Oregon
– -$186K -35,000 Closed
Schroder Investment Management Group
84
Schroder Investment Management Group
United Kingdom
– -$173K -31,295 Closed
Bank of New York Mellon
85
Bank of New York Mellon
New York
– -$123K -23,206 Closed
Verition Fund Management
86
Verition Fund Management
Connecticut
– -$119K -22,485 Closed
SEI Investments
87
SEI Investments
Pennsylvania
– -$93.4K -17,589 Closed
WC
88
Wexford Capital
Florida
– -$81.8K -15,400 Closed
OQS
89
Occudo Quantitative Strategies
Florida
– -$72.2K -13,073 Closed
Deutsche Bank
90
Deutsche Bank
Germany
– -$37.4K -7,045 Closed
CF
91
Corebridge Financial
Texas
– -$30.6K -5,772 Closed
New York State Common Retirement Fund
92
New York State Common Retirement Fund
New York
– -$21.2K -4,100 Closed
PFSRSONJ
93
Police & Firemen's Retirement System of New Jersey
New Jersey
– -$10.8K -2,043 Closed
Legal & General Group
94
Legal & General Group
United Kingdom
– -$5.86K -1,103 Closed
AIP
95
Ameritas Investment Partners
Nebraska
– -$5.29K -996 Closed
California State Teachers Retirement System (CalSTRS)
96
California State Teachers Retirement System (CalSTRS)
California
– -$4.6K -867 Closed
CIAM
97
Caitong International Asset Management
Hong Kong
– -$2.71K -511 Closed
AB
98
Amalgamated Bank
New York
– -$2K -352 Closed
MPWT
99
MassMutual Private Wealth & Trust
Connecticut
– -$786 -148 Closed
SCM
100
Sterling Capital Management
North Carolina
– -$457 -86 Closed
1 2 3
4
5

CRBP Hedge Fund Activity: Q2 2025 in Review

80 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Corbus Pharmaceuticals (CRBP) for Q2 2025, worth a combined $62.5M — up 13% from $55.4M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of CRBP and 15 opened new positions — a net loss of 6 holders — while 29 trimmed existing stakes and 17 added.

The largest buyer was Morgan Stanley, adding an estimated $598K. The largest seller was BlackRock, cutting an estimated $3.59M.

  • 80 institutional investors held Corbus Pharmaceuticals (CRBP) as of Q2 2025, down from 86 in Q1 2025.
  • Funds reported $62.5M of Corbus Pharmaceuticals stock for Q2 2025, up 13% quarter-over-quarter.
  • 15 funds opened new Corbus Pharmaceuticals positions in Q2 2025 and 21 closed out, a net change of -6 holders.
  • The largest Corbus Pharmaceuticals buyer in Q2 2025 was Morgan Stanley, an estimated $598K added.
  • The largest Corbus Pharmaceuticals seller in Q2 2025 was BlackRock, an estimated $3.59M sold.

Based on aggregated 13F filings for Q2 2025.